Clinical Neuropsychologist Online
  • Clinical Neuropsychologist
    • Neuropsychological Assessment
      • What is Clinical Neuropsychology?
      • Our Clinical Neuropsychology Consults
      • Post-COVID Neuropsychological Assessment
      • Neuropsychological Rehabilitation Online & in Hong Kong
    • Our Clinical Neuropsychologist
      • Clinical Neuropsychologist Referral
      • Clinical Neuropsychology Intake Upload
    • Clinical Neuropsychologist Online Appointments
      • Intake Appointment
      • Neuropsychologist Consult
      • Neuropsychology Feedback Session
  • Neuropsychology Knowledgebase
    • Acquired Brain Injury
    • Alzheimer’s Disease Neuropsychology
    • Dementia Neuropsychology
    • Memory Neuropsychology
    • Neuroanatomy & Neuroradiology
    • Neuropsychological Assessment
    • Neuropsychological Disorders
    • Neuropsychological Rehabilitation
    • Traumatic Brain Injury
  • Neuropsychology CPD
    • Latest Journal Articles
    • Cognitive Neuropsychology
    • Dementia
    • Neuro Podcasts
    • Neuroimaging
    • Neuropsychology (general)
    • Neurorehabilitation
    • Neuroscience
    • Paediatric Neuropsychology
  • Neuropsychology Courses
  • Newsletter
  • Brain Lounge
Select Page

Withdrawn: Understanding the progression of Alzheimer’s Disease in 5XFAD transgenic female mice using 1H‐[13C]‐NMR Spectroscopy

by Clinical Neuropsychologist | Wednesday, January 1, 2025 | Dementia

Alzheimer’s &Dementia, EarlyView. If you do not see content above, kindly GO TO SOURCE. Not all publishers encode content in a way that enables republishing at Neuro.vip. This post is Copyright: | January 1, 2025 Wiley: Alzheimer’s & Dementia:...

Spatial proteomic differences in chronic traumatic encephalopathy, Alzheimer’s disease, and primary age‐related tauopathy hippocampi

by Clinical Neuropsychologist | Tuesday, December 31, 2024 | Dementia

Abstract INTRODUCTION Alzheimer’s disease (AD), primary age-related tauopathy (PART), and chronic traumatic encephalopathy (CTE) all feature hyperphosphorylated tau (p-tau)–immunoreactive neurofibrillary degeneration, but differ in neuroanatomical distribution...

Resilience to Alzheimer’s disease associates with alterations in perineuronal nets

by Clinical Neuropsychologist | Tuesday, December 31, 2024 | Dementia

Abstract INTRODUCTION Some individuals show intact cognition despite the presence of neuropathological hallmarks of Alzheimer’s disease (AD). The plasticity of parvalbumin (PV)-containing interneurons might contribute to resilience. Perineuronal nets (PNNs),...

Analysis of semaglutide’s effect on Alzheimer’s disease risk

by Clinical Neuropsychologist | Tuesday, December 31, 2024 | Dementia

Alzheimer’s &Dementia, EarlyView. If you do not see content above, kindly GO TO SOURCE. Not all publishers encode content in a way that enables republishing at Neuro.vip. This post is Copyright: Chi‐Kuei Hsu, Chih‐Cheng Lai | December 31, 2024 Wiley:...

Sex‐dependent molecular landscape of Alzheimer’s disease revealed by large‐scale single‐cell transcriptomics

by Clinical Neuropsychologist | Tuesday, December 31, 2024 | Dementia

Abstract INTRODUCTION Alzheimer’s disease (AD) shows significant sex differences in prevalence and clinical manifestations, but the underlying molecular mechanisms remain unclear. METHODS This study used a large-scale, single-cell transcriptomic atlas of the...
« Older Entries
Next Entries »

Posts by Category

  • Cognitive Neuropsychology
  • Dementia
  • Neuro Podcasts
  • Neuroimaging
  • Neuropsychology (general)
  • Neurorehabilitation
  • Neuroscience
  • Paediatric Neuropsychology

Neuropsychology Newsletter &
Interest List

S U B S C R I B E

  • X
  • RSS
© PsyAsia Neuropsychology. Clinical Neuropsychologist Hong Kong & Online. Part of the Psychology1 Group. All Rights Reserved.
DISCLAIMER: We are not responsible for any inaccuracies at this site. No medical advice is being offered to you personally.
No medical contract is formed by you visiting PsyAsia Neuropsychology. 🕉️🔱☸️